Sue-Ellen Anderson-Haynes, MS, RDN, CDCES, LDN, CPT, previews a panel discussion held at the 83rd Scientific Sessions. Registered participants can view select recordings, including of this session, on the meeting’s virtual platform through August 28.

Presenter Michael R. Rickels, MD, MS, shares insight into a debate that begins Monday at 3:15 p.m. PT in Room 30. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

A symposium beginning Monday at 3:15 p.m. PT in Room 28 will feature panel of diabetes care experts, including Christine Limonte, MD, discussing what is happening in the world of antihyperglycemic and antihypertensive agents—and beyond—as diabetic kidney disease continues to be a prevalent complication from diabetes. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

In a symposium beginning Monday at 3:15 p.m. PT in Ballroom 6A-B, principal Investigator John Kirwan, MSc, PhD, will present ARMMS-T2D study results comparing surgery versus medical and lifestyle intervention in patients with type 2 diabetes, as well as long-term effects post-surgery. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

Presenters Christine P. Limonte, MD, and Ashish Verma, MBBS, share insight into a symposium that begins Monday at 3:15 p.m. PT in Room 28. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

During a symposium beginning Monday at 3:15 p.m. PT in Ballroom 20A-C, Risa Wolf, MD, will share data that suggests GLP-1 receptor agonists can worsen diabetic retinopathy. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

A symposium beginning Monday at 1:30 p.m. PT in Ballroom 20A-C will feature Arun J. Sanyal, MD, and other investigators sharing new data on retatrutide and its effects on obesity, type 2 diabetes, and nonalcoholic steatohepatitis. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

During a panel discussion beginning Monday at 1:30 p.m. PT in Room 28, nephrology and diabetes experts, including Titilayo O. Ilori, MD, MSc, will discuss the impact of race, ethnicity, and underrepresentation of vulnerable populations in clinical trials in relation to diabetes and kidney disease. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

In a symposium beginning Monday at 1:30 p.m. PT in Room 30, investigators including Neha Pagidipati, MD, MPH, will review the results of the COORDINATE-Diabetes trial. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

Presenter Elizabeth J. Rideout, PhD, shares insight into a symposium that begins Monday at 1:30 p.m. PT in Ballroom 6A-B. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

During a professional development session beginning Monday at 11:30 a.m. PT in Ballroom 20A-C, Marie Brown, MD, of the American Medical Association will explain how to effectively address clinical burnout at an organizational level using real-world examples of success centered on practice efficiency. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

Presenter Joanna Mitri, MD, MS, shares insight into a professional interest group discussion that begins Monday at 11:30 a.m. PT in Ballroom 6A-B. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

In a symposium beginning Monday at 8:00 a.m. PT in Room 28, Darren K. McGuire, MD, MHSc, will review sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists as part of an expert panel. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

Presenter Anath Shalev, MD, shares insight into a symposium that begins Monday at 8:00 a.m. PT in Ballroom 20A-C. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

In a symposium beginning Sunday at 4:30 p.m. in Ballroom 20A-C, Vanita R. Aroda, MD, will share results from two trials, OASIS 1 and PIONEER PLUS, and discuss the effectiveness of higher dose semaglutide in treating patients with type 2 diabetes as well as patients with obesity without type 2 diabetes. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

Presenter Revital Nimri, MD, shares insight into a panel discussion that begins Sunday at 4:30 p.m. PT in Ballroom 6A-B. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

Presenter Filip K. Knop, MD, PhD, shares insight into a symposium that begins Sunday at 4:30 p.m. PT in Ballroom 20A-C. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

During a debate beginning Sunday at 3:15 p.m. PT in Room 30, Jennifer Raymond, MD, MCR, will make the case for using telehealth in psychological care, while Michael A. Harris, PhD, will make the case for more research into telehealth models before wide adoption for this kind of care. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

In a debate beginning Sunday at 3:15 p.m. PT in Ballroom 6A-B, James L. Kirkland, MD, PhD, will discuss the use of senolytic drugs, and Anil Bhushan, PhD, will share his immunotherapy approach to eliminate senescent cells. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

Presenter Michael A. Harris, PhD, shares insight into a debate that begins Sunday at 3:15 p.m. PT in Room 30. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

Presenter Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, APh, shares insight into a professional group discussion that begins Sunday at 11:30 a.m. PT in Room 30. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

Presenter Kevin Miller, DO, shares insight into a professional group discussion that begins Sunday at 11:30 a.m. PT in Ballroom 6A-B. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

Presenter Kenneth Cusi, MD, FACP, FACE, shares insight into a symposium that begins Sunday at 8:00 a.m. PT in Ballroom 20A-C. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

During a symposium beginning Sunday at 8:00 a.m. PT in Ballroom 20A-C, experts including Eric L. Johnson, MD, will take a closer look at changes to the American Diabetes Association^® Standards of Care in Diabetes. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

In a symposium beginning Sunday at 8:00 a.m. PT in Room 28, diabetes and cardiovascular experts, including Jan Borén, MD, PhD, will discuss cardiovascular disease and people with diabetes. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

In a new Scientific Sessions event that begins Saturday at 4:30 p.m. PT in Halls GH, six diabetes innovators will have the opportunity to pitch their ideas to a panel of potential funders and a live audience. ADA Chief Scientific and Medical Officer Robert Gabbay, MD, PhD, will be one of the moderators. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

In a symposium that begins Saturday at 4:30 p.m. PT in Ballroom 6A-B, experts including Inês Barroso, PhD, will present information on how GWAS and PRS have helped in the prevention, early diagnosis, and management of type 2 diabetes. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

In a panel discussion that begins Saturday at 3:15 p.m. PT in Ballroom 20A-C, Ellen Leschek, MD, and others will discuss teplizumab clinical trial results and the role of the CD3-directed monoclonal antibody in delaying the progression from stage 2 type 1 diabetes to stage 3. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

Presenter Zhila Semnani-Azad, PhD, shares insight into a symposium that begins Saturday at 4:30 p.m. PT in Ballroom 20A-C. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

Presenter Sue-Ellen Anderson-Haynes, MS, RDN, CDCES, LDN, CPT, shares insight into a panel discussion that begins Saturday at 11:30 a.m. PT in Room 30. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

Presenter Martin A. Thelin, MD, PhD, shares insight into a symposium that begins Saturday at 8:00 a.m. PT in Room 30. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.

In a symposium beginning Saturday at 8:00 a.m. PT in Room 28, David G. Armstrong, DPM, MD, PhD, and other panelists will present approaches providers can implement to help their patients living with diabetes get ahead of foot injuries and improve foot health. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.

During a symposium beginning Saturday at 8:00 a.m. PT in Ballroom 20A-C, panelists including Ronnie Aronson, MD, will discuss CGM’s potential use as a preventative tool and its role for people living with diabetes who are treated with insulin compared to those who are not. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.

In a symposium beginning Saturday at 8:00 a.m. PT in Ballroom 6A-B, experts including Christopher Gardner, PhD, will illustrate a multifaceted understanding of how humans use food and how nutrition can improve health in people with diabetes. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.

Presenter Matthias H. Tschöp, MD, shares insight into a symposium that begins Friday at 3:45 p.m. PT in Ballroom 20A-C at the convention center. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.

In a symposium beginning Friday at 3:45 p.m. PT in Room 28 of the convention center, experts including Stephen E. Gitelman, MD, will present insights from studies of teplizumab and other agents, including abatacept and hydroxychloroquine, that have provided road maps to help delay the onset of type 1 diabetes. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.

In a symposium beginning Friday at 3:45 p.m. PT in Ballroom 20A-C of the convention center, investigators including W. Timothy Garvey, MD, will present results from the SURMOUNT 2 trial of tirzepatide. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.

During oral abstract presentations beginning Friday at 5:30 p.m. PT in Room 28 of the convention center, panelists including Ward Fickweiler, MD, will highlight a variety of factors and their potential associations with diabetic retinopathy. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.

In a symposium beginning Friday at 3:45 p.m. PT in Ballroom 6A-B of the convention center, experts including Aimee Afable, PhD, MPH, will discuss the growing risk of diabetes in populations that immigrate to the U.S. and what may be leading to those risk factors. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.

Presenter Kevin M. Pantalone, DO, ECNU, FACE, shares insight into a symposium that begins Friday at 12:45 p.m. PT in Ballroom 20A-C at the convention center. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.

Presenter Dana M. Lewis shares insight into a debate that begins Friday at 5:30 p.m. PT in Ballroom 20A-C at the convention center. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.

Vera Novak, MD, PhD, discusses the research behind this presentation which begins at 8:10 a.m. CT on Tuesday. A livestream and on-demand recording are available at ADA2022.org.

Maria J. Redondo, MD, PhD, MPH, discusses the research behind this presentation which begins at 8:00 a.m. CT on Tuesday. A livestream and on-demand recording are available at ADA2022.org.

Dongyin Guan, PhD, discusses the research behind this presentation which begins at 7:30 a.m. CT on Tuesday. A livestream and on-demand recording are available at ADA2022.org.

Audrey V. Parent, PhD, discusses the research behind this presentation which begins at 5:30 p.m. CT on Monday. A livestream and on-demand recording are available at ADA2022.org.

“What’s unique about these new classes of drugs is that they’re not glucose-lowering drugs. They’re cardio-renal risk-reducing agents that happen to lower glucose if your kidney function is normal or reasonable,” said George Bakris, MD, who will present during the symposium, which begins at 4:30 p.m. CT on Monday.

Cardiovascular disease is recognized as one of the most common complications of diabetes. Clinicians have long viewed coronary arterial disease and atherosclerosis as the major culprits, but heart failure has emerged as a larger problem—and one that’s more difficult to manage, according to Rong Tian, MD, PhD, who will present during a symposium at 4:30 p.m. CT Monday.

Four cardiologists, including Yi Tan, PhD (left), and Harold E. Bays, MD, will discuss the underlying mechanisms, diagnosis, and treatment of cardiomyopathy, a familiar yet underappreciated complication of diabetes during a symposium at 4:30 p.m. CT on Monday. “My sense is we are on the cusp of some really interesting times in cardiomyopathy in diabetes,” Dr. Bays said.

The ADA and the European Association for the Study of Diabetes will release the latest consensus recommendations on managing hyperglycemia in type 2 diabetes during a special joint session beginning at 4:30 p.m. CT on Monday. The symposium will be co-chaired by ADA Chief Scientific and Medical Officer Robert A. Gabbay, MD, PhD, and EASD President Stefano Del Prato, MD.

Julia E. Blanchette, PhD, RN, BC-ADM, CDCES, discusses the research behind this presentation which begins at 3:45 p.m. CT on Monday. A livestream and on-demand recording are available at ADA2022.org.

Vincent Prevot, PhD, discusses the research behind this presentation which begins at 2:45 p.m. CT on Monday. A livestream and on-demand recording are available at ADA2022.org.

Paul McGuigan, RN, discusses the research behind this presentation which begins at 2:15 p.m. CT on Monday. A livestream and on-demand recording are available at ADA2022.org.

In a symposium at 2:15 p.m. CT on Monday, four diabetes care and education specialists, including Paul McGuigan, RN, CDCES, and Julia E. Blanchette, PhD, RN, BC-ADM, CDCES, will discuss both time-tested and novel approaches to improve the quality-of-life of young people living with diabetes.

Amy K. Mottl, MD, MPH, FASN, will open the joint session, which brings together experts from various disciplines in an effort to improve screening, uptake of practice guidelines, and patient outcomes. The symposium begins at 2:15 p.m. on Monday.

Research examining central nervous system control of systemic metabolism suggests that the CNS plays an important, and perhaps a dominant role in the pathogenesis and progression of at least some forms of diabetes. Four leaders in the field, including Vincent Prevot, PhD, and Sarah Stanley, MB, BCh, PhD, will review the latest findings at 2:15 p.m. CT on Monday.

Noel C. Barengo, MD, PhD, MPH, discusses the research behind this presentation which begins at 12:25 p.m. CT on Monday. A livestream and on-demand recording are available at ADA2022.org.

Ebony B. Carter, MD, MPH, discusses the research behind this presentation which begins at 12:05 p.m. CT on Monday. A livestream and on-demand recording are available at ADA2022.org.

Juan R. Alvarez Dominguez, PhD, discusses the research behind this presentation which begins at 9:00 a.m. CT on Monday. A livestream and on-demand recording are available at ADA2022.org.

Lauren B. Beach, JD, PhD, discusses the research behind this presentation which begins at 6:00 p.m. CT on Sunday. A livestream and on-demand recording are available at ADA2022.org.

In a symposium beginning at 4:30 p.m. CT on Sunday, four experts, including Satish K. Garg, MD, and Holly Willis, PhD, RDN, CDCES, will discuss practical strategies to improve eating habits and optimize the growing number of insulin-dosing options to improve glucose control, increase time in range, reduce A1C, and lower the risk of long-term complications from poor glucose control.

Jamie Feldman, MD, will chair a Scientific Sessions symposium at 4:30 p.m. CT on Sunday examining diabetes, metabolic health, and clinical care among people who are lesbian, gay, bisexual, transgender, gender diverse, queer, or questioning.

Diabetic peripheral neuropathy (DPN) remains undertreated, according to Loretta Vileikyte, MD, PhD (left), who will discuss the psychosocial impact of painful DPN during a symposium beginning at 4:30 p.m. CT on Sunday. Stephanie Eid, PhD, will discuss efforts to develop mechanism-based therapies that impact peripheral neuropathy before irreversible nerve damage occurs.

Shahzeb Khan, MD, MSc, discusses the research behind this presentation which begins at 3:45 p.m. CT on Sunday. A livestream and on-demand recording are available at ADA2022.org.

Anna L. Gloyn, DPhil, discusses the research behind this presentation which begins at 3:45 p.m. CT on Sunday. A livestream and on-demand recording are available at ADA2022.org.

“Heart failure has been a forgotten disorder because the basic and translational science models were created with atherosclerosis in diabetes leading to ischemic heart attacks and strokes. But if you look at the real world, people with diabetes develop heart failure and their mortality is horrific,” said Eldrin F. Lewis, MD, MPH, who will be presenting in this symposium, which starts at 2:15 p.m. on Sunday.

Amit R. Majithia, MD, discusses the research behind this presentation which begins at 2:15 p.m. CT on Sunday. A livestream and on-demand recording are available at ADA2022.org.

Jasmine D. Gonzalvo, PharmD, CDCES, BC-ADM, discusses the research behind this presentation which begins at 9:00 a.m. CT on Sunday. A livestream and on-demand recording are available at ADA2022.org.

Anne Peters, MD, discusses the research behind this presentation which begins at 8:00 a.m. CT on Sunday. A livestream and on-demand recording are available at ADA2022.org.

In a symposium at 8:00 a.m. CT on Sunday, June 5, Hollie Raynor, PhD, RD, and three other expert presenters will review the latest lessons learned for maximizing weight loss maintenance in the U.S. National Diabetes Prevention Program.

Linda A. DiMeglio, MD, MPH, David A. D’Alessio, MD, and Silvia Corvera, MD, will summarize a year’s worth of discovery, innovation, and paradigm shifts in diabetes research and care during the annual Year in Review symposium at 8:00 a.m. CT on Sunday.

In a symposium at 8:00 a.m. CT on Sunday, a multidisciplinary panel including diabetes care and education specialists Jasmine D. Gonzalvo, PharmD, CDCES, BC-ADM (left), and Vivian N. Ayuk, PharmD, CDCES, will discuss educational strategies to help underserved populations overcome barriers to technology access.

The ADA and the European Association for the Study of Diabetes published a consensus report on precision diabetes medicine in 2020. Scientific Sessions attendees will get an update on this joint initiative during a special symposium at 4:00 p.m. CT on Saturday. John M. Dennis, PhD, and David Kerr, MD, are two of the featured presenters.

Krista A. Varady, PhD, discusses the research behind this presentation which begins at 4:00 p.m. CT on Saturday. A livestream and on-demand recording are available at ADA2022.org.

Nicolai Jacob Wewer Albrechtsen, MD, PhD, discusses the research behind this presentation which begins at 2:45 p.m. on Saturday. A livestream and on-demand recording are available at ADA2022.org.

Amy Hess-Fischl, MS, RDN, LDN, BC-ADM, CDCES, and Michelle F. Magee, MD, MB, BCh, LRCPSI, will review the updated national standards for diabetes self-management education and support during a symposium at 1:45 p.m. Saturday. A companion session will outline the revised certification program for certified diabetes care and education specialists.

Ildiko Lingvay, MD, MPH, MSCS, discusses the research behind this presentation which begins at 1:45 p.m. CT on Saturday. A livestream and on-demand recording are available at ADA2022.org.

Nuzhat Chalisa, MD, FACE, discusses the research behind this presentation which begins at 11:55 a.m. CT on Saturday. A livestream and on-demand recording are available at ADA2022.org.

Windy Cole, DPM, CWSP, discusses the research behind this presentation which begins at 11:35 a.m. CT on Saturday. A livestream and on-demand recording are available at ADA2022.org.

There’s no shortage of things to do or sights to see in New Orleans. Founded by the French and later ruled by the Spanish, this one-of-a-kind city is jam-packed with European, Southern, Creole, and Cajun influences.

Mohammad S. Kuchay, MD, DM, discusses the research behind this presentation which begins at 9:00 a.m. CT on Saturday. A livestream and on-demand recording are available at ADA2022.org.

Factors such as sex, gender, age, ethnicity, education, and living environment affect a person’s physical activity. Jane E. Yardley, PhD, and three other experts will share strategies for prescribing physical activity that are feasible and sustainable for various patient groups during a symposium at 8:00 a.m. on Saturday.

It’s hard to go wrong dining out in the Big Easy, a city with rich culinary traditions. But if you’re not comfortable leaving things to chance, check out our restaurant recommendations before heading out for a bite.

Laurel H. Messer, PhD, MPH, RN, CDCES, discusses the research behind this presentation which begins at 5:15 p.m. CT on Friday. A livestream and on-demand recording are available at ADA2022.org.

Katharine R. Barnard-Kelly, PhD, discusses the research behind this presentation which begins at 4:39 p.m. CT on Friday. A livestream and on-demand recording are available at ADA2022.org.

The mental health burden of diabetes remains “grossly underappreciated,” according to Katharine Barnard, PhD. She and other experts will discuss strategies to identify and provide support to diabetes patients at risk for suicide and self-harm during a symposium at 4:15 p.m. CT on Friday.

Elizabeth Selvin, PhD, MPH, discusses the research behind this presentation which begins at 4:45 p.m. CT on Friday. A livestream and on-demand recording are available at ADA2022.org.

David Maahs, MD, PhD, discusses the research behind this presentation which begins at 4:45 p.m. CT on Friday. A livestream and on-demand recording are available at ADA2022.org.

Luis A. Rodriguez, PhD, MPH, RD, discusses the research behind this presentation which begins at 3:12 p.m. CT on Friday. A livestream and on-demand recording are available at ADA2022.org.

Viral N. Shah, MD, discusses the research behind this presentation which begins at 3:00 p.m. CT on Friday. A livestream and on-demand recording are available at ADA2022.org.

Two symposia beginning at 2:00 p.m. CT on Friday will review the latest findings and new treatment strategies to mitigate cardiac and kidney disease in diabetes. “Our patients cross the boundaries between cardiology and diabetes, and we have to do the same to co-manage them more effectively,” said Suzanne V. Arnold, MD, MHA.

In a session at 2:00 p.m. CT on Friday, five diabetes researchers, including Luis A. Rodriguez, PhD, MPH, RD, and Deborah A. Ellis, PhD, will discuss how translational science is being used to promote health equity and address social determinants of health in diabetes prevention and care.

Jim Johnson, PhD, discusses the research behind this presentation which begins at 12:45 p.m. CT on Friday. A livestream and on-demand recording are available at ADA2022.org.

The bionic pancreas, a system that mimics the natural pancreatic regulation of serum glucose by automatically dosing insulin and glucagon, has been a dream for decades. New research to be presented in a mini-symposium at 12:45 p.m. CT on Friday could reveal whether that dream is one step closer to reality, according to Roy W. Beck, MD, PhD.

The American Diabetes Association is pulling back the curtain on its annual updates to the ADA Standards of Care in a mini-symposium beginning at 12:45 p.m. CT on Friday. “We will share how we work with new data that have been published recently to adjust the standards,” said Vanita R. Aroda, MD, a member of the ADA Professional Practice Committee.

In a session at 11:30 a.m. CT on Friday, Maureen Chomko, RD, CDCES, and Alison Evert, MS, RDN, CDCES, will help Scientific Sessions attendees clear up confusion about healthy eating habits so they can have quality conversations about nutrition with their patients.

The stage is set for the 82nd Scientific Sessions in New Orleans, with a robust program featuring 139 invited speaker sessions, 370 oral presentations, and more than 1,000 poster and e-poster presentations covering the hottest topics, latest research discoveries, and emerging trends in diabetes research, prevention, and care. Virtual participation is also an option for those unable to travel.

A combined SGLT1/SGLT2 inhibitor may be the next addition to the armamentarium of drugs for patients with diabetes. Deepak Bhatt, MD, MPH, will explain why and take a comprehensive look at data from recent clinical trials of sotagliflozin from 10:15 a.m. – 12:15 p.m. ET.

Maryam Afkarian, MD, PhD, will explore some of the challenges to the practical application of tools to manage diabetes and kidney disease in a symposium beginning at 9:00 a.m. ET.

Marcus D. Goncalves, MD, PhD, shares details about this presentation, which begins at 9:30 a.m. ET.

New, detailed results of the first Phase 3 SURPASS clinical trials involving tirzepatide will be presented in a dedicated symposium at 8 a.m. “The glucose-lowering and weight reductions of this dual incretin receptor agonist are unprecedented,” said Julio Rosenstock, MD.

Paul W. Franks, PhD, and Kevin D. Hall, PhD, will present opposing viewpoints about whether the hype about precision nutrition outweighs the science during a debate at 8:00 a.m. ET on the final day of the Scientific Sessions.

Manoj Bhasin, PhD, MS, will unveil some of the latest developments in multi-dimensional and spatial single-cell omics in a session beginning at 8:00 a.m. ET.

Michelle M. Kittleson, MD, PhD, and Nasrien E. Ibrahim, MD, will discuss how recent trial results can be leveraged to save lives with angiotensin receptor-neprilysin inhibition and SGLT2 inhibitors. The session begins at 8:00 ET.

Lorenzo Pasquali, MD, PhD, shares details about this presentation, which begins at 9:00 a.m. ET.

Guoxun Chen, PhD, shares details about this presentation, which begins at 4:30 p.m. ET.

Maureen Monaghan, PhD, CDCES, Samantha Kleinberg, PhD, and Jennifer Raymond, MD, MCR, will offer insight into navigating the diabetes digital landscape in a symposium at at 4:30 p.m. ET.

“We hope to give clinicians a comprehensive, comparative view of which drugs do what and in which people,” said GRADE Principal Investigator David Nathan, MD. “It’s about time that we started to find out how these different drugs act in different populations.” GRADE results will be presented at 4:30 p.m. ET.

At 2:15 p.m. ET, Hertzel C. Gerstein, MD, MSc, FRCPC, will offer insight into the use of an exendin-based GLP-1 receptor agonist in people with type 2 diabetes and high cardiovascular risk.

Kelly M. Rawlings, MS, and Marci Butcher, RD, LN, CDCES, FADCES, will discuss digital health and diabetes support in a two-hour symposium at 2:15 p.m. ET.

Carlos A. Monteiro, MD, PhD, will share data on the effects of ultraprocessed foods, while Sung Kyun Park, ScD, MPH, will provide data on per- and polyfluoroalkyl substances in a symposium that begins at 2:15 p.m. ET.

At 2:15 p.m. ET, a joint symposium of the ADA and the International Society for Pediatric and Adolescent Diabetes featuring Richard A. Oram, MD, PhD, and R. Brett McQueen, PhD, will consider general population screening versus targeted screening.

Raghavendra Rao, MD, Charles Stanley, MD, Sarbattama Sen, MD, and Paul Rozance, MD, will address whether neonatal hypoglycemia is overdiagnosed or underestimated in this symposium that begins at 2:15 p.m. ET.

An expert panel including Kathryn Haskins, PhD, Teresa P. DiLorenzo, PhD, and Megan K. Levins, PhD, will discuss the past, present, and future of T cells in diabetes treatment in a symposium starting at 2:15 p.m. ET.

Rajesh Garg, MD, shares details about this presentation, which begins at 12:20 p.m. ET.

Rana K. Gupta, PhD, shares details about this presentation, which begins at 9:30 a.m. ET.

Joseph Aloi, MD, shares details about this presentation, which begins at 9:36 a.m. ET.

Foluso A. Fakorede, MD, shares details about this presentation, which begins at 9:30 a.m. ET.

Guoqiang Gu, PhD, shares details about this presentation, which begins at 8:30 a.m. ET.

The data from continuous glucose monitoring devices can help patients make more informed decisions on lifestyle modifications, insulin dosing, and meal planning. Thomas W. Martens, MD, Dana Gershenoff, MS, RD, CDCES, and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, explain how in a session at 8:00 a.m. ET.

Richard I.G. Holt, PhD, FRCP, and Anne L. Peters, MD, and their writing team will summarize the key topics addressed by this trans-Atlantic collaboration. The session, beginning at 8:00 a.m. ET, will include a live video question and answer period.

Catlin Dennis, MPH, Gretchen Piatt, PhD, MPH, Christine H. Wang, PhD, and Sarah Westen, PhD, will come together in a 4:30 p.m. ET session to help quantify the toll the COVID-19 pandemic has taken on diabetes patients and their families.

Dudley Lamming, PhD, shares details about this presentation, which begins at 4:54 p.m. ET.

Data support the use of telehealth and remote monitoring for patients with diabetes. Leslie A. Eiland, MD, Lindsay S. Mayberry, PhD, MS, and Irl B. Hirsch, MD, will outline how to use these tools for different populations in a session beginning at 4:30 p.m. ET.

The symposium will include a review of treatment options for preproliferative diabetic retinopathy by Jennifer Sun, MD, MPH, and an overview of advancements in retinal neurovascular degeneration in diabetes by Patrice E. Fort, PhD, MS. The session begins at 4:30 p.m. ET.

The Year in Review, from 4:30 p.m. – 6:30 p.m. ET, offers a broad look at advancements in basic, clinical, and translational sciences, putting into context recent research and the future of the field. Speakers include Maureen Gannon, PhD, and Jay S. Skyler, MD, MACP.

Sachin D. Shah, MD, shares details about this presentation, which begins at 3:45 p.m. ET.

DARE-19 Principal Investigator Mikhail Kosiborod, MD, will provide the first look at a subgroup analysis of type 2 diabetes patients who are at higher risk for developing serious complications from COVID-19 in a session beginning at 2:15 p.m. ET.

Leonard E. Egede, MD, MS, shared details about this presentation, which begins at 2:55 p.m. ET.

Bobeck Modjtahedi, MD, shared details about this presentation, which begins at 12:35 p.m. ET.

“The understanding of energy metabolism and its relation to diabetes and obesity is undergoing a revolution,” said Bruce Spiegelman, PhD, one of the researchers who will discuss emerging paradigms of uncoupled bioenergentics in metabolic disease at 8:00 a.m. ET.

Maisa N. Feghali, MD, Randi Streisand, PhD, CDCES, and Jessica Pierce, PhD, will outline how the strategies providers use to promote positive mental health for their patients living with diabetes must evolve as their patients mature. A two-hour session on preserving mental health throughout the lifespan of people with diabetes will begin at 8:00 a.m. ET.

Makoto Fukuda, PhD, and Tune H. Pers, PhD, will discuss GIP signaling in the brain and its effects on food intake and energy balance at 8:00 a.m. ET as part of this year’s ADA Diabetes Symposium.

In a two-hour symposium on developing a more stratified medical approach from the bench to bedside, Emilyn Uy Alejandro, PhD, and Rochelle N. Naylor, MD, will discuss new insights into the heterogeneity of diabetes and how it translates to patient care. The session begins at 4:00 p.m. ET.

Clemence Frerebeau, PhD, shared details about this presentation, which begins at 5:00 p.m. ET.

Yehuda Handelsman, MD, Tina Costacou, PhD, and Sophia Zoungas, MBBS (Hons), PhD, FRACP, will examine the dynamics of weight and cardiovascular risk in type 1 diabetes. The symposium, starting at 4:00 p.m. ET, includes a debate on drugs to prevent cardiovascular disease.

“You could eat a diet of bacon and diet soda all day long and you’d manage your glucose really well. But that wouldn’t be good for your whole health,” said Holly Willis, PhD, RDN, LD. She is part of an expert panel that will discuss the interplay of new technology and advances in the understanding of nutrients’ effects on blood glucose in a two-hour symposium beginning at 4:00 p.m.

Kavita Singh, PhD, shared details about this presentation, which begins at 4:30 p.m. ET.

Inês Barroso, PhD, shared details about this presentation, which begins Saturday, June 26, at 2:15 p.m. ET.

Jeffrey R. Millman, PhD, shared details about this presentation, which begins at 1:45 p.m. ET.

The digital diabetes care market will be worth upward of $700 million in 2022. Anne L. Peters, MD, and Kasia J. Lipska, MD, MHS, BS, will explore whether it is worth the cost in a debate at 1:45 p.m. ET.

In 1921, the discovery of insulin transformed type 1 diabetes from a death sentence. In a special session starting at 1:45 p.m. ET, experts including Peter Arvan, MD, PhD, and Michael A. Weiss, MD, PhD, MBA, will explore the ramifications of this critical inflection point in medicine.

In a session starting at 1:45 p.m. ET Jennifer Sherr, MD, PhD, will highlight new glucagon formulations for treatment, and Nicole de Zoysa, DClinPsych, will review the impact of overcoming psychological obstacles on optimal hypoglycemia management.

The average ages of patients who are potentially eligible for pancreas transplantation and of potential organ donors are on the rise, but that is not the only challenge for this sector of the diabetes community, as Eelco J.P. de Koning, MD, PhD, will explain in a session beginning at 1:45 p.m. ET.

The 2021 Diabetes Care Symposium, featuring speakers Matthew C. Riddle, MD, and Paresh Dandona, MD, PhD, is examining how to mitigate the threefold risk for severe COVID-19 infection among diabetes patients until 10:00 a.m. ET.

Veterans and active-duty military personnel with diabetes can now receive self-management education in a simulated environment. The ADA Education Recognition Program Symposium, from 8:00 a.m. – 10:00 a.m. ET, features a panel of speakers involved in the development of the Virtual Medical Center and new training offered there by the U.S. Department of Veterans Affairs.

Muthiah Vaduganathan, MD, MPH, shares details about this presentation, which begins at 8:30 a.m. ET.

Florin Despa, PhD, shared details about this presentation, which begins at 8:30 a.m. ET.

Ananta Addala, DO, MPH, shared details about this presentation, which begins at 8:25 a.m. ET.

In a symposium beginning at 4:15 p.m. ET, Hui Shao, MD, PhD, will discuss the financial implications on the health care system brought by these classes of agents, which have transformed diabetes care for individuals who also have cardiovascular disease.